NCT02823366.

Trial name or title	Fenofibrate for Patients with Primary Biliary Cirrhosis who had an Inadequate Response to Ursodeoxycholic Acid
Methods	Phase 3, open‐label, randomised clinical trial.
Participants	People with primary biliary cholangitis.
Interventions	Group 1: UDCA + fenofibrate Further details: not provided. Group 2: UDCA. Further details: not provided.
Outcomes	None of the outcomes of interest for this review measured in this trial.
Starting date	January 2016.
Contact information	hanying@fmmu.edu.cn
Notes	Status: recruiting. May be the same as NCT02823353.